CCOc1cc(/C=C2\CN(CC)C/C(=C\c3ccc(O)c(OCC)c3)C2=O)ccc1O.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?